Three of Cork’s highest-achieving female STEM students were today recognised by Stryker, a global leader in medical technologies, at the WISE UP Technological Awards to celebrate outstanding academic ...

Let’s dig into the relative performance of Neogen (NASDAQ:NEOG) and its peers as we unravel the now-completed Q3 medical ...

Despite operational strength, SYK trades at a significant valuation premium to sector peers, with a PEG ratio above 2 and ...

Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of time now. Learn more about SYK stock here.

Stryker (SYK) reported current net profit margins of 12.1%, a step down from last year’s 16.3%, with the latest results ...

Shares of medical technology company Stryker (NYSE:SYK) fell 2.9% in the afternoon session after it reported underwhelming earnings. Stryker's revenue grew 10.2% year on year to $6.06 billion, meeting ...

The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $417.57, accompanied by a ...

Stryker Corp ( ($SYK) ) has released its Q3 earnings. Here is a breakdown of the information Stryker Corp presented to its investors. Stryker ...

Stryker (NYSE:SYK) shares dipped slightly today on third-quarter results that topped the consensus Wall Street forecast.

Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.

The medical device maker posted revenue of $6.06 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $6.04 billion. Stryker expects full-year earnings in ...